p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy

por Kumbrink, Jörg, Li, Pan, Pók-Udvari, Agnes, Klauschen, Frederick, Kirchner, Thomas, Jung, Andreas
Publicado 2021

Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance

por Torlot, Lucien, Jarzab, Anna, Albert, Johanna, Pók-Udvari, Ágnes, Stahler, Arndt, Holch, Julian Walter, Gerlinger, Marco, Heinemann, Volker, Klauschen, Frederick, Kirchner, Thomas, Kumbrink, Jörg, Küster, Bernhard, Jung, Andreas
Publicado 2022